# A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

> **NCT06023966** · — · COMPLETED · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 120 (actual)

## Conditions studied

- Predictive Cancer Model
- Hepatic Metastasis
- Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06023966
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06023966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06023966, "A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06023966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*